title: mTOR Inhibition and Clinical Transplantation: Kidney.
authors.affiliation: Glickman Urological and Kidney Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, OH.
authors.forename: Stuart M
authors.initials: SM
authors.lastname: Flechner
mesh_terms: D065095:Calcineurin Inhibitors / Q000009:adverse effects; D000068338:Everolimus / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D047428:Protein Kinase Inhibitors; D000068338:Everolimus; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus